DeSimone Jill — SEC Form 4 filings
SEC reporting owner CIK 1930479. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-07 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 1 filing — 11,600 shares, $3,611,335 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 2,854 shares @ $311.91 ($890,203) in Praxis Precision Medicines, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | Director | 4 | — | 12 legs · 11,600 sh · $3,611,335 | 8 |
| iTeos Therapeutics, Inc. (ITOS) | Director | 2 | — | — | 2 |
| Kinnate Biopharma Inc. (KNTE) | Director | 1 | — | — | 1 |
| Oncternal Therapeutics, Inc. (ONCT) | Director | 1 | — | — | 1 |
Form 4 filings — DeSimone Jill
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Option exercise (M): 8,566 @ $44.25 · Option exercise (M): 3,034 @ $147.30 · Sale (S): 10 @ $301.44 · Sale (S): 120 @ $303.13 · Sale (S): 320 @ $305.31 · Sale (S): 683 @ $306.77 · +10 more | EDGAR |
| 2026-06-12 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 10,520 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Oncternal Therapeutics, Inc. (ONCT) | Grant/award (A): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 24,200 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 8,566 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Kinnate Biopharma Inc. (KNTE) | Disposition to issuer (D): 50,000 (derivative) | EDGAR |
| 2024-03-07 | 4 | iTeos Therapeutics, Inc. (ITOS) | Grant/award (A): 44,766 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1930479 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →